biomarkerstrategies.biz biomarkerstrategies.biz

BIOMARKERSTRATEGIES.BIZ

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

http://www.biomarkerstrategies.biz/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR BIOMARKERSTRATEGIES.BIZ

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

July

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.4 out of 5 with 14 reviews
5 star
7
4 star
6
3 star
1
2 star
0
1 star
0

Hey there! Start your review of biomarkerstrategies.biz

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

1 seconds

FAVICON PREVIEW

  • biomarkerstrategies.biz

    16x16

  • biomarkerstrategies.biz

    32x32

  • biomarkerstrategies.biz

    64x64

  • biomarkerstrategies.biz

    128x128

CONTACTS AT BIOMARKERSTRATEGIES.BIZ

BioMarker Strategies

855 N.Wol●●●●●●●●●Suite 603

Bal●●●ore , 21205

MD

1.41●●●●1008
1.41●●●●1009
no●●●●●●●●●●●●@worldnic.com

View this contact

BioMarker Strategies

855 N.Wol●●●●●●●●●Suite 603

Bal●●●ore , 21205

MD

1.41●●●●1008
1.41●●●●1009
no●●●●●●●●●●●●@worldnic.com

View this contact

Jennifer Brumbaugh

25 West●●●●●●●ulevard

Haddo●●●●●nship , NJ, 08108

United States US

1.85●●●●2632
jp●●●●●●@comcast.net

View this contact

BioMarker Strategies

855 N.Wol●●●●●●●●●Suite 603

Bal●●●ore , 21205

MD

1.41●●●●1008
1.41●●●●1009
no●●●●●●●●●●●●@worldnic.com

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
n/a
UPDATED
n/a
EXPIRATION
n/a

BUY YOUR DOMAIN

Network Solutions®

NAME SERVERS

1
ns7.worldnic.com
2
ns8.worldnic.com

REGISTRAR

NETWORK SOLUTIONS INC.

NETWORK SOLUTIONS INC.

WHOIS : whois.neulevel.biz

REFERRED :

CONTENT

SCORE

6.2

PAGE TITLE
BioMarker Strategies Homepage | biomarkerstrategies.biz Reviews
<META>
DESCRIPTION
BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.
<META>
KEYWORDS
1 snappath
2 ex vivo
3 our pathmap
4 biomarker strategies
5 info@biomarkerstrategies com
6 recent headlines
7 2017 biomarker strategies
8 coupons
9 reviews
10 scam
CONTENT
Page content here
KEYWORDS ON
PAGE
snappath,ex vivo,our pathmap,biomarker strategies,info@biomarkerstrategies com,recent headlines,2017 biomarker strategies
SERVER
Microsoft-IIS/8.5
POWERED BY
ASP.NET
CONTENT-TYPE
iso-8859-1
GOOGLE PREVIEW

BioMarker Strategies Homepage | biomarkerstrategies.biz Reviews

https://biomarkerstrategies.biz

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

INTERNAL PAGES

biomarkerstrategies.biz biomarkerstrategies.biz
1

Leadership @ BioMarker Strategies

http://www.biomarkerstrategies.biz/leadership.html

Greg Bertenshaw, PhD. Vice President, Research and Development. Chairman and Director;. Co-Founder and Former Chairman and CEO, Dianon Systems. Glenn Miller, PhD. Chair of the Scientific Advisory Board and Director; Former Chief Technology Officer and Executive Vice President, MolecularMD. Chairman and Director;. Co-Founder and Former Chairman and CEO, Dianon Systems. Director, Co-Founder and Former President; President, SJA Healthcare Strategies. Douglas P. Clark,. Glenn Miller, PhD. Dr Greg Bertenshaw,.

2

Media Center @ BioMarker Strategies

http://www.biomarkerstrategies.biz/media.html

Media Center and Key Milestones. June 29, 2016. BioMarker Strategies Awarded Phase I/II Fast Track National Cancer Institute Grant to Develop Companion Diagnostic Test to Select Optimal Therapy for Patients with Non-Small Cell Lung Cancer. Press Release. June 9, 2016. Presentation by BioMarker Strategies President and CEO Jerry Parrott to BIO 2016 International Convention, June 9, 2016, San Francisco. Video. January 7, 2016 -. August 31, 2015 -. March 24, 2014 -. February 11, 2014 -. January 13, 2014 -.

3

BioMarker Strategies Homepage

http://www.biomarkerstrategies.biz/index.html

BioMarker Strategies has developed the proprietary and recently patented SnapPath Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. SnapPath is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. Presentation by B...

4

SnapPath Platform @ BioMarker Strategies

http://www.biomarkerstrategies.biz/system.html

BioMarker Strategies developed the proprietary SnapPath Cancer Diagnostics System*. To guide targeted drug development and treatment selection for patients with solid tumor malignancies. Is the only diagnostics system able to generate purified populations of live solid tumor cells from fresh, unfixed samples in a rapid and standardized manner. SnapPath preserves the molecular integrity of these live cells for. The PathMAP Functional Signaling Profiles enabled by the SnapPath System provide direct informa...

5

Investors and Strategic Partners @ BioMarker Strategies

http://www.biomarkerstrategies.biz/investors.html

BioMarker Strategies is a privately held, Maryland-based limited-liability company located in Rockville, Maryland. To date, the company has been funded by private investors, including the Abell Foundation. BioMarker Strategies has also been awarded approximately $5m in non-dilutive funding from the National Cancer Institute to develop the SnapPath. Platform, including a recent $1.5m Phase II SBIR award to develop a predictive diagnostic test for advanced melanoma patients.

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL PAGES IN THIS WEBSITE

7

OTHER SITES

biomarkersonline.com biomarkersonline.com

biomarkersonline.com -&nbspThis website is for sale! -&nbspdrug biotech pharmaceutical Resources and Information.

The domain biomarkersonline.com. May be for sale by its owner! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.

biomarkersresearch.org biomarkersresearch.org

Official Website of Jawaharlal Nehru Institute of Advanced Studies (JNIAS)

Established by Dr. D. Swaminadhan Research Foundation (DSRF), Hyderabad Recognised by the University Grants Commission (UGC) under section 2(f) and 12 (B) of the UGC Act, 1956 Recognised as an Advanced Research Institute by JNT University Hyderabad (JNTUH) and JNT University Anantapur (JNTUA) Registered under the Indian Trusts Act, 1882- Registration Number: 4794 and Societies Registration Act, 1860- Registration Number S/28158]. UGC and SIRO Recognitions. Advisory Council for Education and Research.

biomarkerstoday.com biomarkerstoday.com

BioMarkers Today – Bridging science with clinical medicine

Bridging science with clinical medicine. Full Frame is a Premium Responsive WordPress Theme. This is promotion headline. You can edit this from Appearance - Customize - Theme Options - Promotion Headline Options. Here you can showcase the x number of Featured Content. You can edit this Headline, Subheadline and Feaured Content from "Appearance - Customize - Featured Content Options". March 15, 2015. March 15, 2015. Remembering a genomics champion, Rep. Louise Slaughter. NIH to host a Reddit Ask Me Anythi...

biomarkerstore.com biomarkerstore.com

Web Page Under Construction

This Site Is Under Construction and Coming Soon. This Domain Is Registered with Network Solutions.

biomarkerstore.net biomarkerstore.net

Web Page Under Construction

This Site Is Under Construction and Coming Soon. This Domain Is Registered with Network Solutions.

biomarkerstrategies.biz biomarkerstrategies.biz

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

biomarkerstrategies.com biomarkerstrategies.com

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

biomarkerstrategies.info biomarkerstrategies.info

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

biomarkerstrategies.net biomarkerstrategies.net

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

biomarkerstrategies.org biomarkerstrategies.org

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.

biomarkerstrategies.us biomarkerstrategies.us

BioMarker Strategies Homepage

BioMarker Strategies has developed the proprietary and recently patented SnapPath. Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. Is unique in automating and standardizing functional. Profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. 15601 Crabbs Branch Way.